METASTATIC NON-SMALL CELL LUNG CANCER
Clinical trials for METASTATIC NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for METASTATIC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung cancer combo trial halted after just 2 patients
Disease control TerminatedThis early-stage trial aimed to test the safety of combining the immunotherapy drug pembrolizumab with targeted radiation (SBRT) in people with advanced non-small-cell lung cancer that had worsened after standard treatments. Only 2 out of a planned 24 patients were enrolled befor…
Matched conditions: METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Experimental cell therapy takes on tough lung cancer
Disease control TerminatedThis early-phase study tested a personalized cell therapy (C-TIL051) for people with advanced non-small cell lung cancer that no longer responded to anti-PD1 drugs. Participants provided a tumor sample to create the therapy, then received chemotherapy, the cell infusion, and addi…
Matched conditions: METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: AbelZeta Inc. • Aim: Disease control
Last updated Apr 23, 2026 12:45 UTC